GI & Endoscopy

John Haydek, MD, is a gastroenterologist at Knoxville, Tenn.-based Gastrointestinal Associates.

Takeda Pharmaceuticals is relocating approximately 100 researchers to Boston during fiscal year 2017, Nikkei Asian Review reports.

A study published in Microbiome examined bidirectional brain-gut microbiome interactions, gut microbial composition and if there are correlations between gut microbial measures and structural brain signatures in irritable bowel syndrome patients.

The American Gastroenterological Association released a new care pathway for managing U.S.-based patients with hepatitis C viral infections.

Here are seven updates on GI companies from the past week.

Here are five updates on GI companies from the past week.

Mark Eisner, MD, is a gastroenterologist at Tampa-based Florida Medical Clinic.

OrphoMed completed a $39 million round of series A financing for the development of its irritable bowel syndrome with diarrhea drug ORP-101.

Pittsfield, Mass.-based Berkshire Health System added Jacques Reichling, MD, to its medical staff, iBerkshires reports.

Minneapolis-based Minnesota Gastroenterology is expanding into Woodbury, Minn., the Woodbury Bulletin reports.